2 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 22753710 | The role of PI3K/mTOR inhibition in combination with sorafenib in hepatocellular carcinoma treatment. | 2012 Jul | 1 |
2 | 21187475 | PI-103 and sorafenib inhibit hepatocellular carcinoma cell proliferation by blocking Ras/Raf/MAPK and PI3K/AKT/mTOR pathways. | 2010 Dec | 1 |